CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
January 2019—Leica Biosystems has partnered with Ultivue to co-market Ultivue’s UltiMapper assays with Leica’s Bond Rx research staining platform. The Ultivue UltiMapper single-step multiplexing assay is pre-optimized for the Bond Rx, enabling a fully automated plug-and-play solution resulting in the creation of 30, five-color, high-performance immunohistochemistry multiplexing slides in less than six hours. Ultivue’s DNA barcode attached to each antibody allows all antibodies to be stained in a single step.
Leica Biosystems, 844-534-2262
Pages: 1 2